α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles (original) (raw)

• Roncarolo, M. & Levings, M. K. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12, 676–683 (2000).
  Article CAS PubMed Google Scholar
• Shevach, E. M. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18, 423–449 (2000).
  Article CAS PubMed Google Scholar
• Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. & Baxter, A. G. NKT cells: facts, functions and fallacies. Immunol. Today 21, 573–583 (2000).
  Article CAS PubMed Google Scholar
• Kronenberg, M. & Gapin, L. The unconventional lifestyle of NKT cells. Nature Rev. Immunol. 2, 557–568 (2002).
  Article CAS Google Scholar
• Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. & Wakao, H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21, 483–513 (2003).
  Article CAS PubMed Google Scholar
• Brigl, M. & Brenner, M. B. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817–890 (2004).
  Article CAS PubMed Google Scholar
• Godfrey, D. I. & Kronenberg, M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114, 1379–1388 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Bendelac, A., Rivera, M. N., Park, S. H. & Roark, J. H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15, 535–562 (1997).
  Article CAS PubMed Google Scholar
• Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J. & Van Kaer, L. NKT cells: what's in a name? Nature Rev. Immunol. 4, 231–237 (2004).
  Article CAS Google Scholar
• Dellabona, P., Padovan, E., Casorati, G., Brockhaus, M. & Lanzavecchia, A. An invariant Vα 24-JαQ/Vβ11 T cell receptor is expressed in all individuals by clonally expanded CD4−8− cells. J. Exp. Med. 180, 1171–1176 (1994).
  Article CAS PubMed Google Scholar
• Porcelli, S., Yockey, C. E., Brenner, M. B. & Balk, S. P. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4−8− αβ T cells demonstrates preferential use of several V β genes and an invariant TCR α chain. J. Exp. Med. 178, 1–16 (1993).
  Article CAS PubMed Google Scholar
• Motsinger, A. et al. Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells. J. Virol. 77, 8153–8158 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Matsuura, A. et al. NKT cells in the rat: organ-specific distribution of NK T cells expressing distinct Vα14 chains. J. Immunol. 164, 3140–3148 (2000).
  Article CAS PubMed Google Scholar
• Shao, H., Van Kaer, L., Sun, S. L., Kaplan, H. J. & Sun, D. Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis. J. Autoimmun. 21, 37–45 (2003).
  Article CAS PubMed Google Scholar
• Bendelac, A. et al. CD1 recognition by mouse NK1+ T lymphocytes. Science 268, 863–865 (1995).
  Article CAS PubMed Google Scholar
• Kawano, T. et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 1626–1629 (1997). This study was the first to show that CD1d-restricted iNKT cells react with α-GalCer.
  Article CAS PubMed Google Scholar
• Schofield, L. et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283, 225–229 (1999).
  Article CAS PubMed Google Scholar
• Gumperz, J. E. et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211–221 (2000).
  Article CAS PubMed Google Scholar
• Fischer, K. et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl Acad. Sci. USA 101, 10685–10690 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, D. Y., Segal, N. H., Sidobre, S., Kronenberg, M. & Chapman, P. B. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198, 173–181 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Stanic, A. K. et al. Defective presentation of the CD1d1-restricted natural Vα14Jα18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency. Proc. Natl Acad. Sci. USA 100, 1849–1854 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Amprey, J. L. et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200, 895–904 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786–1789 (2004).
  Article CAS PubMed Google Scholar
• Lantz, O. & Bendelac, A. An invariant T cell receptor α chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4−8− T cells in mice and humans. J. Exp. Med. 180, 1097–1106 (1994).
  Article CAS PubMed Google Scholar
• Matsuda, J. L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741–754 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Benlagha, K., Weiss, A., Beavis, A., Teyton, L. & Bendelac, A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191, 1895–1903 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Gumperz, J. E., Miyake, S., Yamamura, T. & Brenner, M. B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625–636 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ho, L. P., Urban, B. C., Jones, L., Ogg, G. S. & McMichael, A. J. CD4−CD8αα subset of CD1d-restricted NKT cells controls T cell expansion. J. Immunol. 172, 7350–7358 (2004).
  Article CAS PubMed Google Scholar
• Stetson, D. B. et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069–1076 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Cui, J. et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623–1626 (1997).
  Article CAS PubMed Google Scholar
• Leite-De-Moraes, M. C. et al. IL-4-producing NK T cells are biased towards IFN-γ production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells. Eur. J. Immunol. 28, 1507–1515 (1998).
  Article CAS PubMed Google Scholar
• Gourdy, P. et al. Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-γ production by invariant natural killer T cells. Blood 21 Sep 2004 (doi:10.1182/blood-2004-07-2819).
• Arase, H., Arase, N. & Saito, T. Interferon γ production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J. Exp. Med. 183, 2391–2396 (1996).
  Article CAS PubMed Google Scholar
• Hameg, A. et al. IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1− MHC class I-like/CD1-dependent CD4+ T cells. J. Immunol. 162, 7067–7074 (1999).
  CAS PubMed Google Scholar
• Leite-de-Moraes, M. C. et al. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-TH2 effect of IL-18 exerted through NKT cells. J. Immunol. 166, 945–951 (2001).
  Article CAS PubMed Google Scholar
• Pal, E. et al. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells. J. Immunol. 166, 662–668 (2001).
  Article CAS PubMed Google Scholar
• Hayakawa, Y. et al. Differential regulation of TH1 and TH2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166, 6012–6018 (2001).
  Article CAS PubMed Google Scholar
• Hayakawa, Y., Berzins, S. P., Crowe, N. Y., Godfrey, D. I. & Smyth, M. J. Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors. Nature Immunol. 5, 590–596 (2004). This paper shows that chronic treatment with α-GalCer induces depletion of peripheral iNKT cells in mice and induces the emergence of thymus-derived iNKT cells with an anergic phenotype.
  Article CAS Google Scholar
• Matsuda, J. L. et al. Mouse Vα14_i_ natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl Acad. Sci. USA 100, 8395–8400 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Joyce, S. CD1d and natural T cells: how their properties jump-start the immune system. Cell. Mol. Life Sci. 58, 442–469 (2001).
  Article CAS PubMed Google Scholar
• Van Kaer, L. Regulation of immune responses by CD1d-restricted natural killer T cells. Immunol. Res. 30, 139–153 (2004).
  Article CAS PubMed Google Scholar
• Bendelac, A., Bonneville, M. & Kearney, J. F. Autoreactivity by design: innate B and T lymphocytes. Nature Rev. Immunol. 1, 177–186 (2001).
  Article CAS Google Scholar
• Gombert, J. M. et al. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 26, 2989–2998 (1996).
  Article CAS PubMed Google Scholar
• Baxter, A. G., Kinder, S. J., Hammond, K. J., Scollay, R. & Godfrey, D. I. Association between αβTCR+CD4−CD8− T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46, 572–582 (1997).
  Article CAS PubMed Google Scholar
• Mieza, M. A. et al. Selective reduction of Vα14+ NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156, 4035–4040 (1996).
  CAS PubMed Google Scholar
• Yoshimoto, T., Bendelac, A., Hu-Li, J. & Paul, W. E. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc. Natl Acad. Sci. USA 92, 11931–11934 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Carnaud, C., Gombert, J., Donnars, O., Garchon, H. & Herbelin, A. Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J. Immunol. 166, 2404–2411 (2001).
  Article CAS PubMed Google Scholar
• Esteban, L. M. et al. Genetic control of NKT cell numbers maps to major diabetes and lupus loci. J. Immunol. 171, 2873–2878 (2003).
  Article CAS PubMed Google Scholar
• Matsuki, N. et al. Genetic dissection of Vα14Jα18 natural T cell number and function in autoimmune-prone mice. J. Immunol. 170, 5429–5437 (2003).
  Article CAS PubMed Google Scholar
• Shi, F. D. et al. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc. Natl Acad. Sci. USA 98, 6777–6782 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, B., Geng, Y. B. & Wang, C. R. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194, 313–320 (2001). This paper and references 76, 81 and 82 were the first studies to show the efficacy of α-GalCer for the treatment of autoimmunity, using the NOD mouse model of type 1 diabetes.
  Article PubMed PubMed Central Google Scholar
• Teige, A. et al. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis. J. Immunol. 172, 186–194 (2004).
  Article CAS PubMed Google Scholar
• Yang, J. Q. et al. CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice. Eur. J. Immunol. 34, 1723–1732 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lehuen, A. et al. Overexpression of natural killer T cells protects Vα14–Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831–1839 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Mars, L. T. et al. Vα14–Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J. Immunol. 168, 6007–6011 (2002).
  Article CAS PubMed Google Scholar
• Hammond, K. J. & Godfrey, D. I. NKT cells: potential targets for autoimmune disease therapy? Tissue Antigens 59, 353–363 (2002).
  Article CAS PubMed Google Scholar
• Wilson, S. B. & Delovitch, T. L. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nature Rev. Immunol. 3, 211–222 (2003).
  Article CAS Google Scholar
• Chatenoud, L. Do NKT cells control autoimmunity? J. Clin. Invest. 110, 793–748 (2002).
  Article Google Scholar
• Natori, T., Koezuka, Y. & Higa, T. Agelasphins, novel α-galactosylceramides from the marine sponge Agelas mauritianus. Tetrahedron Lett. 34, 5591–5592 (1993).
  Article CAS Google Scholar
• Morita, M. et al. Structure–activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem. 38, 2176–2187 (1995).
  Article CAS PubMed Google Scholar
• Brossay, L. et al. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521–1528 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Spada, F. M., Koezuka, Y. & Porcelli, S. A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188, 1529–1534 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Eberl, G. & MacDonald, H. R. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 9, 345–353 (1998).
  Article CAS PubMed Google Scholar
• Eberl, G. & MacDonald, H. R. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30, 985–992 (2000).
  Article CAS PubMed Google Scholar
• Wilson, M. T. et al. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl Acad. Sci. USA 100, 10913–10918 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Crowe, N. Y. et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NKT cells. J. Immunol. 171, 4020–4027 (2003).
  Article CAS PubMed Google Scholar
• Harada, M. et al. Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation. Int. Immunol. 16, 241–247 (2004). References 65–67 show that the in vivo disappearance of iNKT cells in response to stimulation with α-GalCer results from the downregulation of the surface receptors that are used to identify this population of cells. References 65 and 66 also show that iNKT cells are capable of substantial in vivo clonal expansion.
  Article CAS PubMed Google Scholar
• Parekh, V. V. et al. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct α- and β-anomeric glycolipids. J. Immunol. 173, 3693–3706 (2004).
  Article CAS PubMed Google Scholar
• Giaccone, G. et al. A phase I study of natural killer T-cell ligand α-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 8, 3702–3709 (2002).
  CAS PubMed Google Scholar
• Nieda, M. et al. Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103, 383–389 (2004).
  Article CAS PubMed Google Scholar
• Singh, N. et al. Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a TH2 phenotype. J. Immunol. 163, 2373–2377 (1999). This paper, together with reference 79, shows that α-GalCer promotes T H 2 responses in C57BL/6 mice.
  CAS PubMed Google Scholar
• Carnaud, C. et al. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647–4650 (1999).
  CAS PubMed Google Scholar
• Diao, H. et al. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21, 539–550 (2004).
  Article CAS PubMed Google Scholar
• Nakagawa, R. et al. Antitumor activity of α-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells. Oncol. Res. 12, 51–58 (2000).
  Article CAS PubMed Google Scholar
• Kitamura, H. et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189, 1121–1128 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Naumov, Y. N. et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl Acad. Sci. USA 98, 13838–13843 (2001). This paper indicates a role for tolerogenic DCs in disease protection.
  Article CAS PubMed PubMed Central Google Scholar
• Kitamura, H. et al. α-Galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell. Immunol. 199, 37–42 (2000).
  Article CAS PubMed Google Scholar
• Nishimura, T. et al. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12, 987–994 (2000).
  Article CAS PubMed Google Scholar
• Burdin, N., Brossay, L. & Kronenberg, M. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards TH2 cytokine synthesis. Eur. J. Immunol. 29, 2014–2025 (1999).
  Article CAS PubMed Google Scholar
• Nagayama, Y., Watanabe, K., Niwa, M., McLachlan, S. M. & Rapoport, B. Schistosoma mansoni and α-galactosylceramide: prophylactic effect of TH1 immune suppression in a mouse model of Graves' hyperthyroidism. J. Immunol. 173, 2167–2173 (2004).
  Article CAS PubMed Google Scholar
• Hong, S. et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nature Med. 7, 1052–1056 (2001).
  Article CAS PubMed Google Scholar
• Sharif, S. et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nature Med. 7, 1057–1062 (2001). References 81 and 82 provide evidence for a role of deviation to a T H 2 response in disease protection.
  Article CAS PubMed Google Scholar
• Fujii, S., Shimizu, K., Kronenberg, M. & Steinman, R. M. Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs. Nature Immunol. 3, 867–874 (2002).
  Article CAS Google Scholar
• Yang, J. -Q. et al. Repeated α-galactosylceramide administration results in expansion of Vα14 NKT cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice. J. Immunol. 171, 4439–4446 (2003). This study shows that α-GalCer ameliorates inflammatory dermatitis but not SLE nephritis in the MRL- lpr/lpr mouse model of SLE. Repeated administration of α-GalCer to these animals induced the clonal expansion of iNKT cells, indicating that CD95–CD95-ligand interactions have a role in the depletion of peripheral iNKT cells after chronic treatment of CD95-sufficient animals with α-GalCer.
  Article CAS PubMed Google Scholar
• Stanic, A. K. et al. Another view of T cell antigen recognition: co-operative engagement of glycolipid antigens by Vα14Jα18 natural T cell receptor. J. Immunol. 171, 4539–4551 (2003).
  Article CAS PubMed Google Scholar
• Cantu, C., Benlagha, K., Savage, P. B., Bendelac, A. & Teyton, L. The paradox of immune molecular recognition of α-galactosylceramide: low affinity, low specificity for CD1d, high affinity for αβ TCRs. J. Immunol. 170, 4673–4682 (2003).
  Article CAS PubMed Google Scholar
• Sidobre, S. et al. The Vα14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J. Immunol. 169, 1340–1348 (2002).
  Article CAS PubMed Google Scholar
• Miyamoto, K., Miyake, S. & Yamamura, T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413, 531–534 (2001). This paper, together with references 98, 99 and 100, shows that α-GalCer and its structural analogue OCH can prevent EAE, in a mechanism that involves deviation to a T H 2 response.
  Article CAS PubMed Google Scholar
• Oki, S., Chiba, A., Yamamura, T. & Miyake, S. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest. 113, 1631–1640 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Goff, R. D. et al. Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells. J. Am. Chem. Soc. 126, 13602–13603 (2004).
  Article CAS PubMed Google Scholar
• Schmieg, J., Yang, G., Franck, R. W. & Tsuji, M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide. J. Exp. Med. 198, 1631–1641 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Ortaldo, J. R. et al. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J. Immunol. 172, 943–953 (2004).
  Article CAS PubMed Google Scholar
• Wilson, M. T., Singh, A. K. & Van Kaer, L. Immunotherapy with ligands of natural killer T cells. Trends Mol. Med. 8, 225–231 (2002).
  Article CAS PubMed Google Scholar
• Delovitch, T. L. & Singh, B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7, 727–738 (1997).
  Article CAS PubMed Google Scholar
• Yasunami, R. & Bach, J. F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18, 481–484 (1988).
  Article CAS PubMed Google Scholar
• Mi, Q. -S., Ly, D., Zucker, P., McGarry, M. & Delovitch, T. L. Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T cells. Diabetes 53, 1303–1310 (2004).
  Article CAS PubMed Google Scholar
• Bollyky, P. L. & Wilson, S. B. CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity. Immunol. Cell. Biol. 82, 307–314 (2004).
  Article PubMed Google Scholar
• Jahng, A. W. et al. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1789–1799 (2001). This paper, together with reference 100, shows that the protocol for administering α-GalCer can considerably impact the treatment outcome.
  Article CAS PubMed PubMed Central Google Scholar
• Singh, A. K. et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1801–1811 (2001). This paper shows that the efficacy of treatment with α-GalCer is genetically controlled.
  Article CAS PubMed PubMed Central Google Scholar
• Furlan, R. et al. Activation of invariant NKT cells by α-GalCer administration protects mice from MOG35–55 induced EAE: critical roles for administration route and IFN-γ. Eur. J. Immunol. 33, 1830–1838 (2003). This paper indicates an unexpected role for IFN-γ in disease protection.
  Article CAS PubMed Google Scholar
• Chiba, A. et al. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of α-galactosylceramide. Arthritis Rheum. 50, 305–313 (2004). This paper shows that α-GalCer moderately protects C57BL/6 mice, but not SJL/J mice, against the development of collagen-induced arthritis. It also shows that the α-GalCer analogue OCH, which elicits a T H 2-biased cytokine response from iNKT cells, can prevent disease in both C57BL/6 and SJL/J mice.
  Article CAS PubMed Google Scholar
• Zeng, D., Liu, Y., Sidobre, S., Kronenberg, M. & Strober, S. Activation of natural killer T cells in NZB/W mice induces TH1-type immune responses exacerbating lupus. J. Clin. Invest. 112, 1211–1222 (2003). This paper indicates that α-GalCer exacerbates disease in the NZB/W mouse model of SLE when treatment is initiated in adult animals. Disease exacerbation in these animals was associated with the unusual induction of T H 1 responses by α-GalCer, instead of the T H 2 response that is induced in most other mouse strains.
  Article CAS PubMed PubMed Central Google Scholar
• Saubermann, L. J. et al. Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterol. 119, 119–128 (2000).
  Article CAS Google Scholar
• Powrie, F. & Coffman, R. L. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today 14, 270–274 (1993).
  Article CAS PubMed Google Scholar
• Pearson, C. I. & McDevitt, H. O. Redirecting TH1 and TH2 responses in autoimmune disease. Curr. Top. Microbiol. Immunol. 238, 79–122 (1999).
  CAS PubMed Google Scholar
• Li, L. et al. IL-4 utilizes an alternative receptor to drive apoptosis of TH1 cells and skews neonatal immunity toward TH2. Immunity 20, 429–440 (2004).
  Article PubMed Google Scholar
• Beaudoin, L., Laloux, V., Novak, J., Lucas, B. & Lehuen, A. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic β cells. Immunity 17, 725–736 (2002).
  Article CAS PubMed Google Scholar
• Mars, L. T., Novak, J., Liblau, R. S. & Lehuen, A. Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks. Trends Immunol. 25, 471–476 (2004).
  Article CAS PubMed Google Scholar
• Abbas, A. K., Murphy, K. M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 383, 787–793 (1996).
  Article CAS PubMed Google Scholar
• Bocek, P., Foucras, G. & Paul, W. E. Interferon γ enhances both in vitro and in vivo priming of CD4+ T cells for IL-4 production. J. Exp. Med. 199, 1619–1630 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Steinman, R. M., Hawiger, D. & Nussenzweig, M. C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685–711 (2003).
  Article CAS PubMed Google Scholar
• Serreze, D. V. et al. TH1 to TH2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J. Immunol. 166, 1352–1359 (2001).
  Article CAS PubMed Google Scholar
• Osman, Y. et al. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur. J. Immunol. 30, 1919–1928 (2000).
  Article CAS PubMed Google Scholar
• Ito, K. et al. Involvement of decidual Vα14 NKT cells in abortion. Proc. Natl Acad. Sci. USA 97, 740–744 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Bilenki, L., Yang, J., Fan, Y., Wang, S. & Yang, X. Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur. J. Immunol. 34, 345–354 (2004).
  Article CAS PubMed Google Scholar
• Tupin, E. et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J. Exp. Med. 199, 417–422 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Nakai, Y. et al. Natural killer T cells accelerate atherogenesis in mice. Blood 104, 2051–2059 (2004).
  Article CAS PubMed Google Scholar
• Major, A. S. et al. Quantitative and qualitative differences in pro-atherogenic NKT cells in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 24, 2351–2357 (2004).
  Article CAS PubMed Google Scholar
• Janeway, C. A. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197–216 (2002).
  Article CAS PubMed Google Scholar
• Treiner, E. et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422, 164–169 (2003).
  Article CAS PubMed Google Scholar
• Yamagata, T., Mathis, D. & Benoist, C. Self-reactivity in thymic double-positive cells commits cells to a CD8αα lineage with characteristics of innate immune cells. Nature Immunol. 5, 597–605 (2004).
  Article CAS Google Scholar